Table 2.
All histologies |
Ductal subtype |
Lobular subtype |
Mixed Ductal-lobular subtype |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Events | HR (95%CI) | Cases | Events | HR (95%CI) | Cases | Events | HR (95%CI) | Cases | Events | HR (95%CI) | |
Parity | Breast cancer-specific mortality | |||||||||||
Nulliparous | 3046 | 445 | 1 | 2463 | 366 | 1 | 235 | 42 | 1 | 108 | 10 | 1 |
1 | 2502 | 401 | 1.06 (0.93 – 1.22) | 2007 | 341 | 1.08 (0.93 – 1.25) | 192 | 24 | 0.82 (0.48 – 1.40) | 100 | 14 | 2.77 (1.02 – 7.50) |
2 | 6469 | 820 | 0.91 (0.81 – 1.02) | 5135 | 679 | 0.89 (0.78 – 1.01) | 550 | 76 | 0.98 (0.65 – 1.48) | 267 | 25 | 1.31 (0.54 – 3.18) |
3 | 4815 | 628 | 0.92 (0.81 – 1.04) | 3787 | 515 | 0.92 (0.80 – 1.05) | 462 | 65 | 0.81 (0.54 – 1.24) | 199 | 19 | 1.70 (0.65 – 4.40) |
4 | 2790 | 371 | 0.86 (0.74 – 0.98) | 2198 | 298 | 0.83 (0.71 – 0.97) | 265 | 41 | 0.89 (0.56 – 1.41) | 85 | 11 | 1.01 (0.33 – 3.09) |
5+ | 2660 | 385 | 0.86 (0.74 – 0.99) | 2088 | 311 | 0.85 (0.73 – 1.00) | 249 | 37 | 0.70 (0.43 – 1.14) | 90 | 9 | 1.93 (0.64 – 5.87) |
PTrend | 0.002 | 0.002 | 0.18 | 0.85 | ||||||||
Parity | All-cause mortality | |||||||||||
Nulliparous | 3046 | 910 | 1 | 2463 | 737 | 1 | 235 | 80 | 1 | 108 | 22 | 1 |
1 | 2502 | 798 | 1.01 (0.92 – 1.11) | 2007 | 659 | 1.03 (0.92 – 1.14) | 192 | 58 | 0.95 (0.66 – 1.35) | 100 | 27 | 1.31 (0.67 – 2.55) |
2 | 6469 | 1634 | 0.91 (0.84 – 0.99) | 5135 | 1325 | 0.90 (0.83 – 0.99) | 550 | 141 | 0.91 (0.68 – 1.22) | 267 | 43 | 0.76 (0.42 – 1.37) |
3 | 4815 | 1281 | 0.90 (0.82 – 0.98) | 3787 | 1031 | 0.90 (0.82 – 0.99) | 462 | 129 | 0.77 (0.57 – 1.03) | 199 | 35 | 0.84 (0.45 – 1.57) |
4 | 2790 | 838 | 0.86 (0.78 – 0.95) | 2198 | 670 | 0.86 (0.77 – 0.96) | 265 | 87 | 0.80 (0.58 – 1.09) | 85 | 18 | 0.52 (0.25 – 1.09) |
5+ | 2660 | 941 | 0.92 (0.84 – 1.01) | 2088 | 753 | 0.92 (0.83 – 1. 02) | 249 | 85 | 0.83 (0.60 – 1.14) | 90 | 21 | 0.84 (0.42 – 1.68) |
PTrend | 0.002 | 0.004 | 0.09 | 0.12 |
HR indicates hazard rate ratio; CI confidence interval
Proportional hazards models were stratified by state of residence, year of interview and age at diagnosis and adjusted for menopausal status, BMI, hormone replacement therapy use, smoking status, mammography, time from date of diagnosis to interview and stage of disease at diagnosis.